Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Voyager Therapeutics (VYGR) Shares Outstanding (Weighted Average): 2015-2025

Historic Shares Outstanding (Weighted Average) for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to $55.5 million.

  • Voyager Therapeutics' Shares Outstanding (Weighted Average) rose 1.72% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year increase of 1.72%. This contributed to the annual value of $54.6 million for FY2024, which is 24.16% up from last year.
  • Per Voyager Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $55.5 million for Q3 2025, which was up 0.24% from $55.3 million recorded in Q2 2025.
  • Voyager Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $55.5 million during Q3 2025, with a 5-year trough of $37.7 million in Q1 2021.
  • Over the past 3 years, Voyager Therapeutics' median Shares Outstanding (Weighted Average) value was $54.4 million (recorded in 2024), while the average stood at $50.8 million.
  • Data for Voyager Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 25.42% (in 2024) over the last 5 years.
  • Over the past 5 years, Voyager Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $38.0 million in 2021, then rose by 1.71% to $38.6 million in 2022, then climbed by 13.96% to $44.0 million in 2023, then climbed by 24.16% to $54.6 million in 2024, then increased by 1.72% to $55.5 million in 2025.
  • Its last three reported values are $55.5 million in Q3 2025, $55.3 million for Q2 2025, and $55.2 million during Q1 2025.